Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

Background: In patients with chronic hepatitis C who do not have a response to antiviral treatment, the disease may progress to cirrhosis, liver failure, hepato-cellular carcinoma, and death. Whether long-term antiviral therapy can prevent progressive liver disease in such patients remains uncertain...

Full description

Bibliographic Details
Main Authors: Mazhar Haque, Eric M. Yoshida, MD, MHSc, FRCP(C), FACP, FACG
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Annals of Hepatology
Subjects:
Hepatitis C
peginterferon
maintenance therapy
cirrhosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119318186

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119318186

Similar Items